Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey.

about

Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey.

Item

http://www.wikidata.org/entity/Q43116036

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@en

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@nl

type

Item

label

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@en

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@nl

prefLabel

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@en

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@nl

P1476

Mesenchymal Stem Cell Treatmen ...... t and First Study from Turkey.

@en

P2093

Arzu Akcay

http://www.w3.org/2001/XMLSchema#string

Ercument Ovali

http://www.w3.org/2001/XMLSchema#string

Fatih Erbey

http://www.w3.org/2001/XMLSchema#string

Gulyuz Ozturk

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.

GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

How I treat refractory acute GVHD.

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

P304

1641402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/1641402

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Didem Atay

P577

2015-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286903944

http://www.w3.org/2001/XMLSchema#string

P698

26783400

http://www.w3.org/2001/XMLSchema#string

P932

4691494

http://www.w3.org/2001/XMLSchema#string